COIAX | LUBYX | COIAX / LUBYX | |
Total Expense Ratio | 0.30 | 0.28 | 107% |
Annual Report Gross Expense Ratio | 0.59 | 0.28 | 211% |
Fund Existence | 9 years | 9 years | - |
Gain YTD | 2.506 | 3.026 | 83% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 1000000 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 996M | 13.9B | 7% |
Annual Yield % from dividends | 4.04 | 4.44 | 91% |
Returns for 1 year | 4.59 | 5.35 | 86% |
Returns for 3 years | 14.75 | 17.05 | 87% |
Returns for 5 years | 15.07 | 16.28 | 93% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JEVNX | 10.35 | 0.02 | +0.19% |
JHancock Disciplined Value Em Mkts EqNAV | |||
JFNAX | 67.65 | 0.10 | +0.15% |
Janus Henderson Global Life Sciences A | |||
SMFPX | 10.43 | 0.01 | +0.10% |
Westwood Salient MLP & Engy Infras C | |||
FCNKX | 24.22 | -0.24 | -0.98% |
Fidelity Contrafund K | |||
VALLX | 44.60 | -0.62 | -1.37% |
Value Line Larger Companies Focused Inv |